Evercyte GmbH
Giulia Corso is currently working in the fields of science and business communication at Evercyte GmbH and is a member at the female factor. With a background in research and academia, Giulia has experience as a postdoctoral researcher and research assistant at various prestigious institutions. Giulia holds a Doctor of Philosophy in Medical Science, specializing in the purification, bioengineering, and profiling of extracellular vesicles. Throughout their career, Giulia has collaborated with various international partners and has a strong background in molecular biology and laboratory work.
This person is not in the org chart
This person is not in any teams
Evercyte GmbH
Evercyte - the pharmacocellomicsTM company. Vision Acceleration of drug finding and development by reduction of development time and cost by introducing panels of immortalized human cell strains for drug screening strategies. Evercyte will establish the new concept of “pharmacocellomicsTM” in the field of pre-clinical developments. Therefore, we will provide primary cells from different patients and tissues that are immortalized by telomerase or other strategies (SV40; SNEV) that we have established. Thus we guarantee cell strains with the most similar phenotype to the primary cells in sufficient amounts to perform reproducible preclinical drug testing. We will deliver (i) single immortalized cell strains including mesenchymal stem cells that can be differentiated to the cell type of interest; (ii) cell panels including sufficient cell strains of different tissues and/or donors of different status (healthy, diseased, young, old, etc) in order to generate statistically meaningful data that allow to estimate drug efficiencies and toxicity with high predictive power. Finally, (iii) we will establish customer-tailored immortalized cell strains according to the needs of specific customers.